We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smartphone Case Offers Glucose Monitoring Regardless of Location

By LabMedica International staff writers
Posted on 20 Dec 2017
Print article
Image: The GPhone is a portable glucose sensing system integrated onto a smartphone (Photo courtesy of David Baillot/UC San Diego Jacobs School of Engineering).
Image: The GPhone is a portable glucose sensing system integrated onto a smartphone (Photo courtesy of David Baillot/UC San Diego Jacobs School of Engineering).
Currently, checking blood sugar levels can be a hassle for people with diabetes, especially when they have to pack their glucose monitoring kits around with them every time they leave the house.

A smartphone case and application have been developed that could make it easier for patients to record and track their blood glucose readings, whether they are at home or on the go. In a proof of concept study the new smartphone-based can be used as a reusable glucose meter.

Bioengineers at the University of California - San Diego (La Jolla, CA, USA) have developed a glucose meter that includes a custom-built smartphone case that houses a permanent bare sensor strip, a stylus that is loaded with enzyme-carbon composite pellets, and sensor instrumentation circuits. A custom-designed Android-based software application was developed to enable easy and clear display of measured glucose concentration.

The device called a GPhone and a typical test involves the user loading the software, using the stylus to dispense an enzymatic pellet on top of the bare sensor strip affixed to the case, and then introducing the sample. The electronic module then acquires and via Bluetooth wirelessly transmits the data to the application software to be displayed on the screen. The deployed pellet is then discarded to regain the fresh bare sensor surface.. The stylus holds enough pellets for 30 tests before it needs to be refilled. A printed circuit board enables the whole system to run off a smartphone battery.

The pellets contain an enzyme called glucose oxidase that reacts with glucose. This reaction generates an electrical signal that can be measured by the sensor's electrodes. The greater the signal, the higher the glucose concentration. The team tested the system on different solutions of known glucose concentrations. The test takes about 20 seconds and the results were accurate throughout multiple tests. The study revealed that the enzyme loaded in the pellets are stable for up to eight months at ambient conditions, and generate reproducible sensor signals.

Joseph Wang, DSc, a professor of Nanoengineering and a senior author of the study, said, “This system is versatile and can be easily modified to detect other substances for use in healthcare, environmental and defense applications.” The study was originally published online on October 17, 2017, in the journal Biosensors and Bioelectronics.

Related Links:
University of California - San Diego

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more